Subscribe To
Plus therapeutics receives $1.9 million advance payment from cprit and plans to present at the cprit innovations in cancer prevention and research conference
AUSTIN, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage ...
September 11, 2023, 7:00 am
Eagle pharmaceuticals to present cal02 trial in progress at the 2023 asm/escmid joint conference on drug development to meet the challenge of antimicrobial resistance
-- CAL02 is a unique therapeutic agent that is designed to work differently from antibiotics, aiming to disarm an infectious pathogen's virulence fact...
September 11, 2023, 6:50 am
Neumora therapeutics sets ipo terms, to be valued at up to $2.7 billion
Neumora Therapeutics Inc. NMRA, has set terms for its initial public offering, as the Massachusetts-based biop...
September 11, 2023, 6:46 am
Softbank-backed neumora therapeutics aims to raise up to $264.8 mln in us ipo
Biopharmaceutical firm Neumora Therapeutics, backed by Amgen and Japan's SoftBank , is aiming to raise ...
September 11, 2023, 6:15 am
Immuron ceo, steven lydeamore to present at h.c. wainwright
MELBOURNE, Australia, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated bio
September 11, 2023, 6:00 am
Adding zymeworks to my value watchlist (initial buy rating)
Zymeworks is a biotech company focused on developing therapies for hard-to-treat cancers. Its lead product, zanidatamab, has shown promising results i...
September 11, 2023, 3:06 am
Allist and arrivent announce interim results from ongoing phase 1b trial with furmonertinib at the 2023 world conference on lung cancer
SHANGHAI, China, Sept. 10, 2023 (GLOBE NEWSWIRE) — Allist pharmaceuticals Co., Ltd. (“Allist”) an...
September 10, 2023, 5:30 am
Only 2 mega-cap monster stocks have risen in each of the last 5 years: are they buys now?
Of the more than 40 current mega-cap stocks, only two have generated positive returns in each of the last five years. One is a highly diversified cong...
September 9, 2023, 5:52 am
Rosen, national trial lawyers, encourages apellis pharmaceuticals, inc. investors to secure counsel before important deadline in securities class action – apls
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...
September 8, 2023, 9:34 pm
Rosen, national trial lawyers, encourages apellis pharmaceuticals, inc. investors to secure counsel before important deadline in securities class action – apls
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...
September 8, 2023, 9:28 pm
: regeneron cfo landry to retire, top accountant fenimore to become cfo
Regeneron pharmaceuticals Inc. REGN said late Friday that Chief Financial Officer Robert E. Landry will...
September 8, 2023, 9:03 pm
Regeneron provides update on planned chief financial officer transition
Robert E. Landry to retire effective February 2024; Christopher Fenimore, long-standing Senior Vice President, Head of Accounting and Controller, to a...
September 8, 2023, 8:46 pm
Regeneron cfo landry to retire, top accountant fenimore to become cfo
Regeneron pharmaceuticals Inc. REGN, +0.66% said late Friday that Chief Financial Officer Robert E. Lan...
September 8, 2023, 5:03 pm
What makes olema pharmaceuticals, inc. (olma) a new buy stock
Olema pharmaceuticals, Inc. (OLMA) might move higher on growing optimism about its earnings prospects, ...
September 8, 2023, 1:32 pm
Why is ionis pharmaceuticals (ions) up 1.4% since last earnings report?
Ionis pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock?...
September 8, 2023, 12:47 pm
Recursion pharmaceuticals has a prescription for high drug costs: ai and 25 petabytes of data
Amid fierce debate about prescription-drug prices and countless proposals to rein them in, there has been a point of widespread agreement: Those price...
September 8, 2023, 12:38 pm
Syndax pharmaceuticals: positive axatilimab phase 2 results
Syndax is making strides in the adoption of entinostat, a cancer therapeutic used in combination with immune checkpoint therapies. Syndax reported an ...
September 8, 2023, 10:42 am
What makes olema pharmaceuticals, inc. (olma) a good fit for 'trend investing'
Olema pharmaceuticals, Inc. (OLMA) could be a great choice for investors looking to make a profit from ...
September 8, 2023, 10:32 am
1 top pharma growth stock to buy today and hold forever
Vertex pharmaceuticals has many avenues for chasing growth both big and small. Its cystic fibrosis medi...
September 8, 2023, 10:15 am
The 3 best pharma stocks to buy now: september 2023
The pharmaceutical sector will always be a sector in constant evolution and growth. As technology advan...
September 8, 2023, 9:14 am